Clinical treatment of cluster headache with the serotonergic indoleamine psychedelics psilocybin and LSD and with ketamine: A case series
Background Cluster headache is an excruciating condition for which standard treatments are usually insufficient. Evidence has accumulated that serotonergic psychedelic indoleamines including psilocybin and LSD can be effective in preventing attacks. Methods In this case series, nine patients with ep...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-05-01
|
| Series: | Cephalalgia Reports |
| Online Access: | https://doi.org/10.1177/25158163251345472 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849716759742906368 |
|---|---|
| author | Jonathan Leighton Carmen Lau Aisha Savdo Livia Granata |
| author_facet | Jonathan Leighton Carmen Lau Aisha Savdo Livia Granata |
| author_sort | Jonathan Leighton |
| collection | DOAJ |
| description | Background Cluster headache is an excruciating condition for which standard treatments are usually insufficient. Evidence has accumulated that serotonergic psychedelic indoleamines including psilocybin and LSD can be effective in preventing attacks. Methods In this case series, nine patients with episodic and chronic cluster headache that didn’t respond to conventional treatments were treated at a clinic with psilocybin or LSD, under compassionate use provisions, and in most cases separately with ketamine. Results All patients responded positively to at least one of the treatments, and eight of nine responded positively to the treatment with the psychedelic indoleamines, in several cases with extended periods free of attacks. Conclusion These clinical data, though of an exploratory nature, add to the existing pool of evidence for the usefulness of these substances for treating cluster headache, and further support the lowering of legal and regulatory barriers to medical access to the psychedelic indoleamines. |
| format | Article |
| id | doaj-art-0d756f7bcea34a4e9365c3bd6ec84a02 |
| institution | DOAJ |
| issn | 2515-8163 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Cephalalgia Reports |
| spelling | doaj-art-0d756f7bcea34a4e9365c3bd6ec84a022025-08-20T03:12:53ZengSAGE PublishingCephalalgia Reports2515-81632025-05-01810.1177/25158163251345472Clinical treatment of cluster headache with the serotonergic indoleamine psychedelics psilocybin and LSD and with ketamine: A case seriesJonathan Leighton0Carmen Lau1Aisha Savdo2Livia Granata3 Organisation for the Prevention of Intense Suffering (OPIS), Geneva, Switzerland Organisation for the Prevention of Intense Suffering (OPIS), Geneva, Switzerland Schmerzzentrum Granata, Clinical, Zurich, Switzerland Schmerzzentrum Granata, Clinical, Zurich, SwitzerlandBackground Cluster headache is an excruciating condition for which standard treatments are usually insufficient. Evidence has accumulated that serotonergic psychedelic indoleamines including psilocybin and LSD can be effective in preventing attacks. Methods In this case series, nine patients with episodic and chronic cluster headache that didn’t respond to conventional treatments were treated at a clinic with psilocybin or LSD, under compassionate use provisions, and in most cases separately with ketamine. Results All patients responded positively to at least one of the treatments, and eight of nine responded positively to the treatment with the psychedelic indoleamines, in several cases with extended periods free of attacks. Conclusion These clinical data, though of an exploratory nature, add to the existing pool of evidence for the usefulness of these substances for treating cluster headache, and further support the lowering of legal and regulatory barriers to medical access to the psychedelic indoleamines.https://doi.org/10.1177/25158163251345472 |
| spellingShingle | Jonathan Leighton Carmen Lau Aisha Savdo Livia Granata Clinical treatment of cluster headache with the serotonergic indoleamine psychedelics psilocybin and LSD and with ketamine: A case series Cephalalgia Reports |
| title | Clinical treatment of cluster headache with the serotonergic indoleamine psychedelics psilocybin and LSD and with ketamine: A case series |
| title_full | Clinical treatment of cluster headache with the serotonergic indoleamine psychedelics psilocybin and LSD and with ketamine: A case series |
| title_fullStr | Clinical treatment of cluster headache with the serotonergic indoleamine psychedelics psilocybin and LSD and with ketamine: A case series |
| title_full_unstemmed | Clinical treatment of cluster headache with the serotonergic indoleamine psychedelics psilocybin and LSD and with ketamine: A case series |
| title_short | Clinical treatment of cluster headache with the serotonergic indoleamine psychedelics psilocybin and LSD and with ketamine: A case series |
| title_sort | clinical treatment of cluster headache with the serotonergic indoleamine psychedelics psilocybin and lsd and with ketamine a case series |
| url | https://doi.org/10.1177/25158163251345472 |
| work_keys_str_mv | AT jonathanleighton clinicaltreatmentofclusterheadachewiththeserotonergicindoleaminepsychedelicspsilocybinandlsdandwithketamineacaseseries AT carmenlau clinicaltreatmentofclusterheadachewiththeserotonergicindoleaminepsychedelicspsilocybinandlsdandwithketamineacaseseries AT aishasavdo clinicaltreatmentofclusterheadachewiththeserotonergicindoleaminepsychedelicspsilocybinandlsdandwithketamineacaseseries AT liviagranata clinicaltreatmentofclusterheadachewiththeserotonergicindoleaminepsychedelicspsilocybinandlsdandwithketamineacaseseries |